trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - keuhkosairaus, krooninen obstruktiivinen - obstruktiivisten hengitystiesairauksien lääkkeet, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
entocort 3 mg depotkapseli, kova
paranova oy - budesonide - depotkapseli, kova - 3 mg - budesonidi
budenofalk 4 mg peräpuikko
dr. falk pharma gmbh - budesonide - peräpuikko - 4 mg - budesonidi
pulmicort 50 mikrog/annos inhalaatioaerosoli
aktiebolaget draco - budesonidum - inhalaatioaerosoli - 50 mikrog/annos - budesonidi
preferid 0.025 % emulsiovoide
tika läkemedel ab - budesonidum - emulsiovoide - 0.025 % - budesonidi
preferid 0.025 % voide
tika läkemedel ab - budesonidum - voide - 0.025 % - budesonidi
pulmicort 200 mikrog/annos inhalaatioaerosoli
aktiebolaget draco - budesonidum - inhalaatioaerosoli - 200 mikrog/annos - budesonidi
rhinocort 50 mikrog/annos nenäaerosoli
aktiebolaget draco - budesonidum - nenäaerosoli - 50 mikrog/annos - budesonidi
preferid 0.025 % emulsiovoide
yamanouchi europe b.v. - budesonidum - emulsiovoide - 0.025 % - budesonidi
preferid 0.025 % voide
yamanouchi europe b.v. - budesonidum - voide - 0.025 % - budesonidi